Aqua Bio Technology ASA logo

ABT - Aqua Bio Technology ASA Share Price

NOK8.85 0.7  7.9%

Last Trade - 25/02/21

Sector
Consumer Defensives
Size
Micro Cap
Market Cap £11.7m
Enterprise Value £11.6m
Revenue £31.5k
Position in Universe 1528th / 1874
Bullish
Bearish
Unlock ABT Revenue
Momentum
Relative Strength (%)
1m -20.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -39.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.98 0.38 0.000 1.21 0.88 0.89 26.6 34.6 -1.9%
+73.6 +271.1 -42.7
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Aqua BioTechnology ASA revenues decreased 75% to NOK144K. Net lossdecreased 26% to NOK6.4M. Revenues reflect a decrease indemand for the Company's products and services due tounfavorable market conditions. Lower net loss reflectsFinancial income increase from NOK35K to NOK1.3M (income),Other selling expenses decrease of 7% to NOK6.3M (expense),Salaries decrease of 21% to NOK925K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for ABT
Graphical History

Revenue

ABT Revenue Unlock ABT Revenue

Net Income

ABT Net Income Unlock ABT Revenue

Normalised EPS

ABT Normalised EPS Unlock ABT Revenue

PE Ratio Range

ABT PE Ratio Range Unlock ABT Revenue

Dividend Yield Range

ABT Dividend Yield Range Unlock ABT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ABT EPS Forecasts Unlock ABT Revenue
Profile Summary

Aqua Bio Technology ASA is a Norway-based company active within the biotechnology sector. The Company is primarily engaged in the development, production and marketing of active ingredients for the global personal care industry. Its portfolio comprises two main products: Aquabeautine XL and SMIDS. Aquabeautine XL is a product derived from the hatching fluid of salmon. It removes the dead cells in the outer layer of the skin, initiating and accelerating the renewal and healing process of the skin. SMIDS is a bio-polymer system based on raw-materials from natural marine sources. It provides a method for tailoring the melting point of a cosmetic composition and forms a bio-film that enhances the water content and softness of the skin. Aqua Bio Technology ASA is a parent company of Kilda Biolink AS (previously Aqua Bio Technology AS).

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated March 9, 2004
Public Since January 10, 2008
No. of Shareholders: n/a
No. of Employees: 2
Sector Consumer Defensives
Industry Personal & Household Products & Services
Index
Exchange Oslo Stock Exchange
Shares in Issue 15,873,371
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ABT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ABT
Upcoming Events for ABT
Frequently Asked Questions for Aqua Bio Technology ASA
What is the Aqua Bio Technology ASA share price?

As of 25/02/21, shares in Aqua Bio Technology ASA are trading at NOK8.85, giving the company a market capitalisation of £11.7m. This share price information is delayed by 15 minutes.

How has the Aqua Bio Technology ASA share price performed this year?

Shares in Aqua Bio Technology ASA are currently trading at NOK8.85 and the price has moved by 0.272k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Aqua Bio Technology ASA price has moved by 0.243k% over the past year.

What are the analyst and broker recommendations for Aqua Bio Technology ASA?

There are no analysts currently covering Aqua Bio Technology ASA.

When will Aqua Bio Technology ASA next release its financial results?

Aqua Bio Technology ASA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Aqua Bio Technology ASA dividend yield?

Aqua Bio Technology ASA does not currently pay a dividend.

Does Aqua Bio Technology ASA pay a dividend?

Aqua Bio Technology ASA does not currently pay a dividend.

When does Aqua Bio Technology ASA next pay dividends?

Aqua Bio Technology ASA does not currently pay a dividend.

How do I buy Aqua Bio Technology ASA shares?

To buy shares in Aqua Bio Technology ASA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Aqua Bio Technology ASA?

Shares in Aqua Bio Technology ASA are currently trading at NOK8.85, giving the company a market capitalisation of £11.7m.

Where are Aqua Bio Technology ASA shares listed? Where are Aqua Bio Technology ASA shares listed?

Here are the trading details for Aqua Bio Technology ASA:

Country of listing: Norway
Exchange: OSL
Ticker Symbol: ABT
What kind of share is Aqua Bio Technology ASA?

Based on an overall assessment of its quality, value and momentum, Aqua Bio Technology ASA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Aqua Bio Technology ASA share price forecast 2021?

Shares in Aqua Bio Technology ASA are currently priced at NOK8.85. At that level they are trading at 1.69% discount to the analyst consensus target price of 0.00.

Analysts covering Aqua Bio Technology ASA currently have a consensus Earnings Per Share (EPS) forecast of 0.21 for the next financial year.

How can I tell whether the Aqua Bio Technology ASA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aqua Bio Technology ASA. Over the past six months, the relative strength of its shares against the market has been 41.5%. At the current price of NOK8.85, shares in Aqua Bio Technology ASA are trading at 49.58% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Aqua Bio Technology ASA PE Ratio?

We were not able to find PE ratio data for Aqua Bio Technology ASA.

Who are the key directors of Aqua Bio Technology ASA?

Aqua Bio Technology ASA's management team is headed by:

Tone Bjornov - DRC
Arvid Lindberg - DSL
Espen Kvale - CEO
Hans Leren - CTO
Kristin Aase - DRC
Edvard Cock - CHM
Roger Hofseth - DRC
Jan Pettersson - DRC
Who are the major shareholders of Aqua Bio Technology ASA?

Here are the top five shareholders of Aqua Bio Technology ASA based on the size of their shareholding:

Finnvick Eiendom AS Corporation
Percentage owned: 24.4% (4.49m shares)
Swelandia International Aktiebolag Corporation
Percentage owned: 13.59% (2.50m shares)
Dahl (Espen Halvard) Individual Investor
Percentage owned: 9.12% (1.68m shares)
Aase (Kristin) Individual Investor
Percentage owned: 7.68% (1.41m shares)
BLIXEN INVEST AS Corporation
Percentage owned: 6.96% (1.28m shares)
Similar to ABT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.